Go to the M. D. Anderson Home Page

Back to the PTSG Home Page


News and Progress
Pancreatic Cancer -Frequently Asked Questions
Diagnosis and Treatment
Clinical Studies
Who are the Pancreatic Tumor Study Group specialists?
How to refer a patient for evaluation
Pancreatic Cancer Survivors
From Bench to Bedside: Basic Science Research

From Bench to Bedside:
Causation and Prevention


The most consistently identified epidemiological risk factor for pancreatic cancer is cigarette smoking. A 2-10-fold risk of developing pancreatic cancer has been demonstrated for heavy smokers. In addition, there appears to be a potential relationship between the development of pancreatic cancer and environmental carcinogens, such as a high fat, low fier diet, industrial carcinogens, and radiation exposure. Most carcinogens need to be activated by drug-metabolizing enzymees into reactive molecules which can then exert their carcinogenic effect. Human pancreatic tissues have been shown to contain thse carcinogen-activating enzymes, such as nitrosamine compounds, which are present in both the human diet and cigarette smoke.

These compounds exert their carcinogenic effect by inducing damage in DNA. We have demonstrated that damaged DNA can be detected in human pancreatic cancers. This research is ongoing with specific emphasis on developing a better understanding of the relationship between cigarette smoking and the development of pancreatic cancer at a molecular level.

Selected References:

Wang M, Abbruzzese JL, Friess H, Hittelman WN, Evans DB, Abbruzzese MC, 
Chiao P,Donghi L.  DNA adducts in human pancreatic tissues and their potential 
role in carcinogenesis.  Cancer Res 1998;58:38-41.